Literature DB >> 29889278

Marburg and Ravn Virus Infections Do Not Cause Observable Disease in Ferrets.

Gary Wong1,2,3,4,5, Zirui Zhang1,3, Shihua He1, Marc-Antoine de La Vega5, Kevin Tierney1, Geoff Soule1, Kaylie Tran1, Lisa Fernando1, Xiangguo Qiu1,3.   

Abstract

Ferrets are used for studying infections with wild-type Ebola virus isolates. Here, we investigated whether these animals are also susceptible to wild-type isolates of Marburg virus (MARV). Ferrets were challenged intramuscularly or intranasally with MARV strain Angola and monitored for 3 weeks. Unexpectedly, the animals neither showed observable signs of disease nor died of infection, and viremia was not detected after challenge. All animals were seropositive for MARV-specific immunoglobulin antibodies. Confirmatory studies with MARV strain Musoke and Ravn virus yielded the same outcomes. Therefore, ferrets may be of limited usefulness for studying the pathogenesis of MARV and Ravn virus infections.

Entities:  

Mesh:

Year:  2018        PMID: 29889278      PMCID: PMC6249572          DOI: 10.1093/infdis/jiy245

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Ferrets Infected with Bundibugyo Virus or Ebola Virus Recapitulate Important Aspects of Human Filovirus Disease.

Authors:  Robert Kozak; Shihua He; Andrea Kroeker; Marc-Antoine de La Vega; Jonathan Audet; Gary Wong; Chantel Urfano; Kym Antonation; Carissa Embury-Hyatt; Gary P Kobinger; Xiangguo Qiu
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

2.  Successful treatment of Marburg virus with orally administrated T-705 (Favipiravir) in a mouse model.

Authors:  Wenjun Zhu; Zirui Zhang; Shihua He; Gary Wong; Logan Banadyga; Xiangguo Qiu
Journal:  Antiviral Res       Date:  2018-02-03       Impact factor: 5.970

Review 3.  A Comparison of the Pathogenesis of Marburg Virus Disease in Humans and Nonhuman Primates and Evaluation of the Suitability of These Animal Models for Predicting Clinical Efficacy under the 'Animal Rule'.

Authors:  Elizabeth R Glaze; Michael J Roy; Lonnie W Dalrymple; Lynda L Lanning
Journal:  Comp Med       Date:  2015-06       Impact factor: 0.982

4.  Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies.

Authors:  Eri Nakayama; Ayaka Yokoyama; Hiroko Miyamoto; Manabu Igarashi; Noriko Kishida; Keita Matsuno; Andrea Marzi; Heinz Feldmann; Kimihito Ito; Masayuki Saijo; Ayato Takada
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

5.  Comparison of the Pathogenesis of the Angola and Ravn Strains of Marburg Virus in the Outbred Guinea Pig Model.

Authors:  Robert W Cross; Karla A Fenton; Joan B Geisbert; Hideki Ebihara; Chad E Mire; Thomas W Geisbert
Journal:  J Infect Dis       Date:  2015-06-19       Impact factor: 5.226

6.  Pathogenesis of experimental Ebola virus infection in guinea pigs.

Authors:  B M Connolly; K E Steele; K J Davis; T W Geisbert; W M Kell; N K Jaax; P B Jahrling
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

7.  Development and characterization of a mouse model for Marburg hemorrhagic fever.

Authors:  Kelly L Warfield; Steven B Bradfute; Jay Wells; Loreen Lofts; Meagan T Cooper; D Anthony Alves; Daniel K Reed; Sean A VanTongeren; Christine A Mech; Sina Bavari
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

8.  Development and Characterization of a Guinea Pig-Adapted Sudan Virus.

Authors:  Gary Wong; Shihua He; Haiyan Wei; Andrea Kroeker; Jonathan Audet; Anders Leung; Todd Cutts; Jill Graham; Darwyn Kobasa; Carissa Embury-Hyatt; Gary P Kobinger; Xiangguo Qiu
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

9.  The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus.

Authors:  Robert W Cross; Chad E Mire; Viktoriya Borisevich; Joan B Geisbert; Karla A Fenton; Thomas W Geisbert
Journal:  J Infect Dis       Date:  2016-05-24       Impact factor: 5.226

10.  A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever.

Authors:  Andrea Marzi; Logan Banadyga; Elaine Haddock; Tina Thomas; Kui Shen; Eva J Horne; Dana P Scott; Heinz Feldmann; Hideki Ebihara
Journal:  Sci Rep       Date:  2016-12-15       Impact factor: 4.379

View more
  4 in total

1.  Ebola virus, but not Marburg virus, replicates efficiently and without required adaptation in snake cells.

Authors:  Greg Fedewa; Sheli R Radoshitzky; Xiǎolì Chī; Lián Dǒng; Xiankun Zeng; Melissa Spear; Nicolas Strauli; Melinda Ng; Kartik Chandran; Mark D Stenglein; Ryan D Hernandez; Peter B Jahrling; Jens H Kuhn; Joseph L DeRisi
Journal:  Virus Evol       Date:  2018-11-28

Review 2.  Recent advances in marburgvirus research.

Authors:  Judith Olejnik; Elke Mühlberger; Adam J Hume
Journal:  F1000Res       Date:  2019-05-21

Review 3.  Pathogenicity and virulence of Marburg virus.

Authors:  Mehedy Hasan Abir; Tanjilur Rahman; Ayan Das; Silvia Naznin Etu; Iqbal Hossain Nafiz; Ahmed Rakib; Saikat Mitra; Talha Bin Emran; Kuldeep Dhama; Ariful Islam; Abolghasem Siyadatpanah; Shafi Mahmud; Bonlgee Kim; Mohammad Mahmudul Hassan
Journal:  Virulence       Date:  2022-12       Impact factor: 5.882

Review 4.  Marburg virus pathogenesis - differences and similarities in humans and animal models.

Authors:  Kyle Shifflett; Andrea Marzi
Journal:  Virol J       Date:  2019-12-30       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.